What is the official ID of this bill?

The official print number for this legislation is S 3200.

When did the legislative process begin?

The process officially started on 2023-11-02.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/s3200/BILLS-118s3200is.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Who is the primary sponsor?

The primary sponsor is Sen. Hassan, Margaret Wood [D-NH].

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Analysis and Potential Impact of S 3200

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Doubled funding and tax relief for substance use disorder treatment staff.

Q: What are the main provisions?

Key points include: Funding for the loan repayment program for substance use disorder treatment staff is doubled from $25 million to $50 million annually for fiscal years 2024 through 2028. Loan repayment amounts received by professionals under this program will be exempt from federal income tax. The tax exemption provides a major financial incentive to attract and retain more healthcare workers in the critical field of addiction treatment.

This act reauthorizes and doubles the funding for the loan repayment program aimed at professionals treating substance use disorders. Crucially, these loan repayments will no longer be considered taxable income, making the program significantly more appealing to doctors and therapists. The goal is to increase the number of available specialists and improve access to care for those struggling with addiction.

Key points

Funding for the loan repayment program for substance use disorder treatment staff is doubled from $25 million to $50 million annually for fiscal years 2024 through 2028.

Loan repayment amounts received by professionals under this program will be exempt from federal income tax.

The tax exemption provides a major financial incentive to attract and retain more healthcare workers in the critical field of addiction treatment.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act

Print number: S 3200

Sponsor: Sen. Hassan, Margaret Wood [D-NH]

Process start date: 2023-11-02

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-09-2025

Source data: api.congress.gov

AI work logs for this document launch

Doubled funding and tax relief for substance use disorder treatment staff.

Key Questions about Doubled funding and tax relief for substance use disorder treatment staff.